Subtypes


Web

  • http://www.drugs.com/mtm/ribavirin.html
  • Ribavirin is an antiviral medication.Ribavirin must be used together with an interferon alfa product (such as Pegasys, PegIntron, Sylatron, or Intron A) to treat chronic hepatitis C.
  • http://www.medicines.org.uk/emc/medicine/3237
  • Rebetol must be used in combination therapy as described in section 4.1.
  • http://www.netdoctor.co.uk/medicines/infections/a8681/rebetol-rib...
  • Rebetol capsules contain the active ingredient ribavirin, which is a type of medicine called a nucleoside analogue.
  • http://www.uwhealth.org/health/topic/multum/copegus/d00085a1.html
  • Ribavirin is not effective when used alone to treat hepatitis C. It must be used together with an interferon alfa product (such as Pegasys, PegIntron, Sylatron, or Intron A) to treat chronic hepatitis C.
  • http://keckmedicine.adam.com/content.aspx?productId=45&pid=45&gid=1147
  • There may be other brand names for this medicine.
  • http://www.wikidoc.org/index.php/Ribavirin_(patient_information)
  • Ribavirin will not treat hepatitis C (a virus that infects the liver and may cause severe liver damage or liver cancer) unless it is taken with another medication.
  • http://www.nps.org.au/medicines/infections-and-infestations/antiv...
  • Rebetol Capsules is a brand of medicine containing the active ingredient ribavirin (antiviral medicines).
  • http://www.diagnosia.com/en/drug/rebetol-200-mg-hard-capsules
  • Rebetol hard capsules contain the active ingredient ribavirin.Rebetol stops the multiplication of many types of viruses, including hepatitis C virus.
  • http://www.allinahealth.org/CCS/doc/Detailed_Drugs/47/602577.htm
  • Ribavirin is not effective for monotherapy treatment of chronic hepatitis C virus infection.
  • https://en.wikipedia.org/wiki/Ribavirin
  • Ribavirin is a guanosine (ribonucleic) analog used to stop viral RNA synthesis and viral mRNA capping, thus, it is a nucleoside inhibitor.[2] Its brand names include Copegus, Rebetol, Ribasphere, Vilona, and Virazole.
  • 1 2 3 4 5 6 7 8 9

    News

    Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia
    Nature - Thursday, November 29, 2018
    Ribavirin for Treating Crimean Congo Hemorrhagic Fever
    Science Daily - Saturday, July 28, 2018
    Ribavirin and QoL in HCV-infected Patients Ribavirin and QoL in HCV-infected Patients
    Med Worm - Monday, May 28, 2018
    EBR +/- GZR +/- Ribavirin in HCV Genotype 2, 4, 5 or 6 EBR +/- GZR +/- Ribavirin in HCV Genotype 2, 4, 5 or 6
    Med Worm - Monday, May 14, 2018
    Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithua
    Hepatmon - Monday, February 26, 2018
    Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice
    Cambridge - Sunday, February 4, 2018
    Ribavirin for treating Crimean Congo haemorrhagic fever
    Wiley - Wednesday, July 12, 2017
    Copegus ribavirina - Copegus ribavirin 200 mg ????
    Utahpoliticalcapitol - Sunday, May 28, 2017
    Sofosbuvir and Ribavirin With or Without Pegylated Interferon for Hepatitis C Genotype 3: A Real World Experience
    Hepatmon - Monday, April 24, 2017
    Comments on "The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3"
    Hepatmon - Thursday, March 30, 2017
    Hepatitis C Virus-Related Hepatic Myelopathy After Treatment With Sofosbuvir and Ribavirin: A Case R ...
    Annals of Internal Medicine - Tuesday, March 7, 2017
    The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3
    Hepatmon - Saturday, January 28, 2017
    Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs
    Wolters Kluwer Health - Wednesday, January 11, 2017
    Ribavirin suppresses bacterial virulence by targeting LysR-type transcriptional regulators
    Nature - Monday, December 19, 2016
    Sofosbuvir and ribavirin in acute hepatitis C-infected patient with decompensated cirrhosis
    Wolters Kluwer Health - Saturday, December 10, 2016
    The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin...
    Wolters Kluwer Health - Saturday, November 19, 2016
    Probable Interaction ID'd for PrOD, Ribavirin With Warfarin
    Physicians Briefing - Wednesday, November 9, 2016
    MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin
    Nature - Monday, September 26, 2016
    MORE NEWS

    Videos

    Peginterferon & Ribavirin
         
    Interferons are proteins that are normally made by your body. Interferons fight viral infections. Peginterferon is a long acting type of interferon. Peginterferon is a medicine that helps to fight chronic viral infections like hepatitis. Ribavirin is a m...

    Peginterferon & Ribavirin
           
    Interferons are proteins that are normally made by your body. Interferons fight viral infections. Peginterferon is a long acting type of interferon. Peginterferon is a medicine that helps to fight chronic viral infections like hepatitis. Ribavirin is a m...

    TUAB0207LB - Daclatasvir plus sofosbuvir with or without ribavirin in patients with HIV-HCV ...
           
    TUAB0207LB - Daclatasvir plus sofosbuvir with or without ribavirin in patients with HIV-HCV co-infection: interim analysis of a French multicenter compassionate use program K. Lacombe1, H. Fontaine2, C. Dhiver3, E. Rosenthal4, S. Metivier5, T. Antonini-Mi...

    Images

    Ribavirin ball-and-stick.png
    200px Ribavirin svg
    120px Ribavirin svg
    ribavirin str
    ribavirin fig 1
    Ribavirin ball-and-stick.png
    en.wikipedia.org
    200px Ribavirin svg
    en.wikipedia.org
    120px Ribavirin svg
    en.wikipedia.org
    ribavirin str
    drugs.com
    ribavirin fig 1
    drugs.com
    rebetol 01
    Copegus 200 mg
    copegus 02
    copegus 01
    The molecular formula of ribavirin is C8H12N4O5 and the molecular weight is 244.2. Ribavirin is a white to off-white powder.
    rebetol 01
    drugs.com
    Copegus 200 mg
    drugs.com
    copegus 02
    drugs.com
    copegus 01
    drugs.com
    The molecular formula of ribavirin is C8H12N4O5 and the molecular weight is 244.2. Ribavirin is a white to off-white powder.
    drugs.com
    REBETOL 200 MG
    Ribasphere 200mg
    Virazole
    Ribavirin is a stable, white crystalline compound with a maximun solubility in water of 142 mg/mL at 25C and with only a slight solubility in ethanol.
    Moderiba (ribavirin) 200 mg
    REBETOL 200 MG
    drugs.com
    Ribasphere 200mg
    drugs.com
    Virazole
    drugs.com
    Ribavirin is a stable, white crystalline compound with a maximun solubility in water of 142 mg/mL at 25
    drugs.com
    Moderiba (ribavirin) 200 mg
    drugs.com
    Image of Ribavirin 200 mg Tab-TEV
    Image of Ribavirin 200 mg-TEV
    ribavirin (oral)
    Cover of Peginterferon Alfa and Ribavirin for Chronic Hepatitis C in Patients Eligible for Shortened Treatment, Re-Treatment or in HCV/HIV Co-Infection: A Systematic Review and Economic Evaluation
    Ribavirin, an antiviral drug, has been used with success in Lassa fever patients.
    Image of Ribavirin 200 mg Tab-TEV
    uwhealth.org
    Image of Ribavirin 200 mg-TEV
    uwhealth.org
    ribavirin (oral)
    uwhealth.org
    Cover of Peginterferon Alfa and Ribavirin for Chronic Hepatitis C in Patients Eligible for Shortened Treatment, Re-Treatment or in HCV/HIV Co-Infection: A Systematic Review and Economic Evaluation
    ncbi.nlm.nih.gov
    Ribavirin, an antiviral drug, has been used with success in Lassa fever patients.
    cdc.gov
    Ribavirin Molecular Structure .png
    Ribavirin 1
    In Study NR15961, patients with CHC/HIV were randomized to receive either peginterferon alfa-2a 180 mcg subcutaneous once weekly plus an oral placebo, peginterferon alfa-2a 180 mcg once weekly plus ribavirin 800 mg by mouth daily or interferon alfa-2a, 3
    tablets ribavirin generic sandoz
    tablets ribavirin emcopegusem
    Ribavirin Molecular Structure .png
    wikidoc.org
    Ribavirin 1
    wikidoc.org
    In Study NR15961, patients with CHC/HIV were randomized to receive either peginterferon alfa-2a 180 mcg subcutaneous once weekly plus an oral placebo, peginterferon alfa-2a 180 mcg once weekly plus ribavirin 800 mg by mouth daily or interferon alfa-2a, 3
    wikidoc.org
    tablets ribavirin generic sandoz
    hepatitisc.uw.edu
    tablets ribavirin emcopegusem
    hepatitisc.uw.edu
    capsules ribavirin generic teva
    bottle ribavirin emcopegusem
    Peginterferon alfa-2a with or without Ribavirin
    Interferon alfa-2b Alone or in Combination with Ribavirin
    Peginterferon alfa-2b and Weight-Based or Flat-Dose Ribavirin (WINR-Trial)
    capsules ribavirin generic teva
    hepatitisc.uw.edu
    bottle ribavirin emcopegusem
    hepatitisc.uw.edu
    Peginterferon alfa-2a with or without Ribavirin
    hepatitisc.uw.edu
    Interferon alfa-2b Alone or in Combination with Ribavirin
    hepatitisc.uw.edu
    Peginterferon alfa-2b and Weight-Based or Flat-Dose Ribavirin (WINR-Trial)
    hepatitisc.uw.edu
    Treatment-experienced patients with genotype 1 HCV and compensated cirrhosis received either a 12-week course of ledipasvir-sofosbuvir and ribavirin or a 24-week course of ledipasvir-sofosbuvir. The SVR12 rates were similar in the two groups.
    In the ION-2 trial, treatment-naive patients received 12 or 24 weeks of ledipasvir-sofosbuvir; patients with cirrhosis had better SVR12 rates if they received 24 weeks of therapy. The addition of ribavirin to the regimen did not significantly improve SVR
    Patients with genotype 1 HCV in Cohort 2 (F3 or F4 fibrosis) of the COSMOS trial received treatment with a 12- or 24-week course of sofosbuvir and simeprevir, with or without ribavirin.
    ribavirin biopartners 200 mg film coated tablets en GB em 41 3
    Number of 200 mg tablets If the childadolescent weighs kg Usual daily Ribavirin Teva Pharma B.V. dose 47-49 600 mg 1 tablet in the morning and 2 tablets in the evening 50-65 800 mg 2 tablets in the morning or 1 400 mg tablet in the morning and 2 tablets i
    Treatment-experienced patients with genotype 1 HCV and compensated cirrhosis received either a 12-week course of ledipasvir-sofosbuvir and ribavirin or a 24-week course of ledipasvir-sofosbuvir. The SVR12 rates were similar in the two groups.
    hepatitisc.uw.edu
    In the ION-2 trial, treatment-naive patients received 12 or 24 weeks of ledipasvir-sofosbuvir; patients with cirrhosis had better SVR12 rates if they received 24 weeks of therapy. The addition of ribavirin to the regimen did not significantly improve SVR
    hepatitisc.uw.edu
    Patients with genotype 1 HCV in Cohort 2 (F3 or F4 fibrosis) of the COSMOS trial received treatment with a 12- or 24-week course of sofosbuvir and simeprevir, with or without ribavirin.
    hepatitisc.uw.edu
    ribavirin biopartners 200 mg film coated tablets en GB em 41 3
    diagnosia.com
    Number of 200 mg tablets If the childadolescent weighs kg Usual daily Ribavirin Teva Pharma B.V. dose 47-49 600 mg 1 tablet in the morning and 2 tablets in the evening 50-65 800 mg 2 tablets in the morning or 1 400 mg tablet in the morning and 2 tablets i
    diagnosia.com
    Ribavirin Teva Pharma B.V. tablets for oral use dose based on body weight If the adult weighs kg Number of 200 mg tablets Usual daily Ribavirin Teva Pharma B.V. dose 65 800 mg 2 tablets in the morning or 1 400 mg tablet in the morning and 2 tablets in the
    Number of 200 mg tablets If the childadolescent weighs kg Usual daily Ribavirin Teva Pharma B.V. dose 47-49 600 mg 1 tablet in the morning and 2 tablets in the evening 50-65 800 mg 2 tablets in the morning or 1 400 mg tablet in the morning and 2 tablets i
    Ribavirin Teva hard capsules for oral use dose based on body weight Number of 200 mg capsules If the adult weighs kg Usual daily Ribavirin Teva dose 65 800 mg 2 capsules in the morning and 2 capsules in the evening 65 80 1,000 mg 2 capsules in the morning
    Rebetol oral solution Usual Dosage in Children If the patient weighs this many kg Measure and give this dose Morning Dose Evening Dose 10-12 2 ml 2 ml 13-14 3 ml 2 ml 15-17 3 ml 3 ml 18-20 4 ml 3 ml 21-22 4 ml 4 ml 23-25 5 ml 4 ml 26-28 5 ml 5 ml 29-31 6
    The plastic oral dosing syringe consists of two parts, an opaque barrel, and a white plunger rod that fits into the barrel. The rod is marked with 0.5 ml markings starting at 1.5 ml at the very top of the rod and ending at 10 ml. A. Insert the assembled d
    Ribavirin Teva Pharma B.V. tablets for oral use dose based on body weight If the adult weighs kg Number of 200 mg tablets Usual daily Ribavirin Teva Pharma B.V. dose 65 800 mg 2 tablets in the morning or 1 400 mg tablet in the morning and 2 tablets in the
    diagnosia.com
    Number of 200 mg tablets If the childadolescent weighs kg Usual daily Ribavirin Teva Pharma B.V. dose 47-49 600 mg 1 tablet in the morning and 2 tablets in the evening 50-65 800 mg 2 tablets in the morning or 1 400 mg tablet in the morning and 2 tablets i
    diagnosia.com
    Ribavirin Teva hard capsules for oral use dose based on body weight Number of 200 mg capsules If the adult weighs kg Usual daily Ribavirin Teva dose 65 800 mg 2 capsules in the morning and 2 capsules in the evening 65 80 1,000 mg 2 capsules in the morning
    diagnosia.com
    Rebetol oral solution Usual Dosage in Children If the patient weighs this many kg Measure and give this dose Morning Dose Evening Dose 10-12 2 ml 2 ml 13-14 3 ml 2 ml 15-17 3 ml 3 ml 18-20 4 ml 3 ml 21-22 4 ml 4 ml 23-25 5 ml 4 ml 26-28 5 ml 5 ml 29-31 6
    diagnosia.com
    The plastic oral dosing syringe consists of two parts, an opaque barrel, and a white plunger rod that fits into the barrel. The rod is marked with 0.5 ml markings starting at 1.5 ml at the very top of the rod and ending at 10 ml. A. Insert the assembled d
    diagnosia.com

    MORE IMAGES